Each product in the Spektus portfolio targets a specific segment and patient population within the depression market.
Breakable 24hr XR tablets with fast onset of action for those where weight control and libido drive the decision.
Breakable once-daily tablets allowing the full efficacy of an SNRI to those where depression is pain-related.
Three segment, short duration tablets to help patients fall asleep, stay asleep and wake refreshed.
Titratable tablets providing all key strengths from a single script to patients lacking the enjoyment in life.
